Skip to main content
Premium Trial:

Request an Annual Quote

Genome Compiler, DNA2.0 Partner on Synthetic Biology Software

NEW YORK (GenomeWeb) – Genome Compiler today announced a collaboration under which it will integrate DNA2.0's gene synthesis services into its computer-aided synthetic biology design platform.

"Direct connection to DNA2.0 services will simplify the design to order user experience, giving a more streamlined approach to the programming of living things," Omri Drory, CEO of Genome Compiler, said in a statement.

Genome Compiler, with offices in Los Altos, Calif. and Tel-Aviv, Israel, is a software developer creating computer-aided design and collaboration platforms for the synthetic biology industry.

Menlo Park, Calif.-based bioengineering firm DNA2.0 offers an integrated pipeline for designing, optimizing, and synthesizing genes and proteins.

In March, DNA2.0 licensed the technology underlying its Gene Designer software to Genome Compiler, ending a patent dispute between the two firms.

Financial and other terms of the deal were not disclosed.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.